Fresenius SE KGaA (XSWX:FRE) Growth Rank: 4 (As of Jul. 01, 2026) — 56% Below Median


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF36.15
GF Value CHF33.34
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Growth Rank?

Fresenius SE KGaA XSWX:FRE 71 Growth Rank is 4 as of Jul. 01, 2026, which is 56% below its 10-year median of 9.00. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.34 (Fairly Valued). The stock has 5 warning signs investors should review.

Fresenius SE KGaA has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Fresenius SE KGaA Growth Rank Related Terms

XSWX:FRE vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius SE KGaA Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Growth Rank distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Growth Rank falls into.


XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 4 mean?
Fresenius SE KGaA (XSWX:FRE) has a Growth Rank of 4 as of Jul. 01, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Fresenius SE KGaA and its competitors. This is 56% below median its historical median of 9.00. Over the past decade, Fresenius SE KGaA's Growth Rank has ranged from 3.00 to 10.00.
Is Fresenius SE KGaA's Growth Rank too high?
Fresenius SE KGaA's current Growth Rank of 4 is 56% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Growth Rank compare to HCA and THC?
Fresenius SE KGaA's Growth Rank of 4 can be compared against companies in the Healthcare Providers & Services industry. Historically, Fresenius SE KGaA's own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Growth Rank is 4, which is 56% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.34, compared to a current price of CHF36.15 — trading 8.4% above its estimated fair value. The current Growth Rank is 4, which is 56% below median its 10-year median of 9.00. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Growth Rank is 4 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF36.15 is trading 8.4% above its estimated GF Value™ of CHF33.34. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • Growth Rank: 4 (56% below median its 10-year median of 9.00)
  • GF Value™: CHF33.34 vs. price of CHF36.15 (8.4% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF36.15
Price
CHF33.34
GF Value